First National Bank of Omaha’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-13,435
| Closed | -$2.83M | – | 334 |
|
|
2022
Q1 | $2.83M | Sell |
13,435
-784
| -6% | -$170K | 0.14% | 160 |
|
|
2021
Q4 | $3.41M | Sell |
14,219
-767
| -5% | -$197K | 0.16% | 151 |
|
|
2021
Q3 | $4.24M | Sell |
14,986
-570
| -4% | -$187K | 0.22% | 142 |
|
|
2021
Q2 | $4.35M | Hold |
15,556
| – | – | 0.23% | 136 |
|
|
2021
Q1 | $4.35M | Buy |
15,556
+307
| +2% | +$82.8K | 0.23% | 136 |
|
|
2020
Q4 | $3.73M | Sell |
15,249
-378
| -2% | -$97.5K | 0.2% | 142 |
|
|
2020
Q3 | $4.43M | Sell |
15,627
-163
| -1% | -$45.5K | 0.28% | 118 |
|
|
2020
Q2 | $4.22M | Buy |
15,790
+42
| +0.3% | +$12.6K | 0.28% | 118 |
|
|
2020
Q1 | $4.98M | Sell |
15,748
-13
| -0.1% | -$3.94K | 0.39% | 85 |
|
|
2019
Q4 | $4.68M | Sell |
15,761
-584
| -4% | -$162K | 0.28% | 122 |
|
|
2019
Q3 | $3.81M | Sell |
16,345
-287
| -2% | -$66.8K | 0.25% | 132 |
|
|
2019
Q2 | $3.89M | Buy |
16,632
+45
| +0.3% | +$10.4K | 0.25% | 133 |
|
|
2019
Q1 | $3.92M | Sell |
16,587
-213
| -1% | -$67.1K | 0.27% | 124 |
|
|
2018
Q4 | $5.06M | Sell |
16,800
-3,677
| -18% | -$1.17M | 0.38% | 91 |
|
|
2018
Q3 | $7.2M | Sell |
20,477
-269
| -1% | -$92.6K | 0.4% | 83 |
|
|
2018
Q2 | $6.17M | Buy |
20,746
+21
| +0.1% | +$5.9K | 0.36% | 89 |
|
|
2018
Q1 | $5.87M | Sell |
20,725
-177
| -0.8% | -$54.9K | 0.35% | 92 |
|
|
2017
Q4 | $6.72M | Sell |
20,902
-348
| -2% | -$112K | 0.39% | 81 |
|
|
2017
Q3 | $6.73M | Buy |
21,250
+2,545
| +14% | +$754K | 0.41% | 76 |
|
|
2017
Q2 | $5.28M | Sell |
18,705
-1,081
| -5% | -$286K | 0.33% | 100 |
|
|
2017
Q1 | $5.61M | Sell |
19,786
-1,682
| -8% | -$476K | 0.34% | 100 |
|
|
2016
Q4 | $6.26M | Buy |
21,468
+2,624
| +14% | +$778K | 0.39% | 83 |
|
|
2016
Q3 | $5.9M | Sell |
18,844
-598
| -3% | -$177K | 0.43% | 81 |
|
|
2016
Q2 | $4.7M | Buy |
19,442
+507
| +3% | +$134K | 0.35% | 102 |
|
|
2016
Q1 | $4.93M | Sell |
18,935
-640
| -3% | -$169K | 0.37% | 95 |
|
|
2015
Q4 | $6K | Sell |
19,575
-274
| -1% | -$78.7K | 0.43% | 87 |
|
|
2015
Q3 | $5.79K | Sell |
19,849
-8,995
| -31% | -$2.97M | 0.43% | 88 |
|
|
2015
Q2 | $10.8K | Hold |
28,844
| – | – | 0.74% | 30 |
|
|
2015
Q1 | $10.8K | Buy |
28,844
+146
| +0.5% | +$57.5K | 0.74% | 30 |
|
|
2014
Q4 | $9.74M | Buy |
28,698
+2,347
| +9% | +$759K | 0.68% | 31 |
|
|
2014
Q3 | $8.72M | Sell |
26,351
-1,398
| -5% | -$461K | 0.63% | 39 |
|
|
2014
Q2 | $8.75M | Buy |
27,749
+2,142
| +8% | +$645K | 0.62% | 39 |
|
|
2014
Q1 | $7.83M | Sell |
25,607
-6,181
| -19% | -$1.96M | 0.58% | 49 |
|
|
2013
Q4 | $8.89M | Buy |
31,788
+1,888
| +6% | +$488K | 0.68% | 35 |
|
|
2013
Q3 | $7.2M | Buy |
29,900
+42
| +0.1% | +$9.4K | 0.62% | 44 |
|
|
2013
Q2 | $6.42K | Buy |
+29,858
| New | +$6.38M | 0.55% | 54 |
|
Other funds holding BIIB
First National Bank of Omaha's BIIB Position: Q2 2022 in Review
First National Bank of Omaha sold out of Biogen (BIIB) in Q2 2022, closing a stake of 13,435 shares — an estimated $2.83M sold.
First National Bank of Omaha first reported a position in BIIB in Q2 2013 and held it in 36 quarters. The position peaked at $9.74M in Q4 2014. 928 funds tracked by Wall St. Rank hold BIIB as of Q2 2022.
- First National Bank of Omaha reported no remaining Biogen position as of Q2 2022 after selling out during the quarter.
- First National Bank of Omaha sold 13,435 Biogen shares in Q2 2022, an estimated $2.83M.
- First National Bank of Omaha first reported a position in Biogen in Q2 2013 and held it in 36 quarters.
- First National Bank of Omaha's Biogen position peaked at $9.74M in Q4 2014.
- 928 funds tracked by Wall St. Rank held Biogen as of Q2 2022.
Based on First National Bank of Omaha's 13F filing for Q2 2022, filed 6 Sep 2022.